This study, to be launched in both Canada and the US, will be an open, multi-center trial treating patients with addictions to assess the effectiveness of using the MedX laser probe as a means of controlling the need for these substances.
The MedX multi-center trial will determine the effectiveness of laser acupuncture for treating a number of major health conditions that significantly contribute to morbidity and mortality. MedX will be working with sites across the US and Canada to enroll patients interested in participating in studies using low level laser therapy for auricular acupuncture for smoking, drug or alcohol abuse.
The research results will assist in guiding clinical practice and increasing the likelihood of successful outcomes for patients experiencing an array of significant health issues, the company said.
Steve Guillen, president and CEO of MedX Health, said: While the use of laser therapy in addiction is not a new concept, it has not been well-documented and it is important that MedX conduct these meaningful studies to confirm the efficacy of our laser and established treatment protocols for these addictions. This would lead to a more cost-effective way to treat addiction.